🧪
hypothesis

Synaptic-Selective Autophagy Receptor Expression to Bypass Axonal Lysosome Deficiency

Hypothesis

Synaptic-Selective Autophagy Receptor Expression to Bypass Axonal Lysosome Deficiency

Synaptic-Selective Autophagy Receptor Expression to Bypass Axonal Lysosome Deficiency.
🧬 SQSTM1 (p62/sequestosome 1)🩺 proteomics🎯 Composite 37%💱 $0.46▲11.5%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates 5 support 6 oppose
⚠ Missing Evidence⚠ Thin Description Senate Quality Gates →
Mechanistic 0.40 (15%) Evidence 0.40 (15%) Novelty 0.70 (12%) Feasibility 0.35 (12%) Impact 0.40 (12%) Druggability 0.30 (10%) Safety 0.35 (8%) Competition 0.30 (6%) Data Avail. 0.40 (5%) Reproducible 0.45 (5%) KG Connect 0.50 (8%) 0.370 composite
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite37%

🧪 Overview

Synaptic-Selective Autophagy Receptor Expression to Bypass Axonal Lysosome Deficiency

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Axonal Lysosome<br/>Deficiency"]
    B["Synaptic-Selective<br/>Autophagy Receptor"]
    C["SQSTM1/p62 Binding<br/>to Ubiquitinated Cargo"]
    D["Autophagosome<br/>Formation Bypassing soma"]
    E["Synaptic Protein<br/>Clearance"]
    F["Axonal Integrity<br/>Preserved"]
    G["Bypasses Axonal<br/>Lysosome Deficit"]
    A --> B
    B --> C
    C --> D
    D --> E
    E --> F
    G -.->|"enables"| D
    style A fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style F fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7

⚖️ Evidence

⚖️ Evidence Matrix5 supports6 contradicts
Supports
Autophagosomes form at presynaptic terminals but rarely fuse with lysosomes in mature neurons
PMID:28760822
Supports
Synaptic overexpression of p62 in Drosophila reduces neurodegeneration from autophagy impairment
PMID:25327251
Supports
AAV9-mediated gene delivery targets synapses in adult CNS with high efficiency
PMID:25369104
Supports
p62/SQSTM1 recognizes ubiquitinated cargo for autophagic degradation
PMID:24456934
Supports
Synaptic proteostasis impairment is upstream of neurodegeneration
PMID:30401736
Contradicts
p62-positive aggregates ARE pathological - diagnostic of NBD, ALS/FTLD
PMID:24456934
Contradicts
Creating 'sink compartment' without functional lysosomes merely relocates aggregates
PMID:24456934
Contradicts
p62 coalesces into inclusions that sequester autophagy machinery components (ULK1, Vps34), further impairing process
PMID:24456934
Contradicts
p62 aggregates recruit and inactivate mTORC1, creating feedforward dysregulation
PMID:28628113
Contradicts
p62 lacks transmembrane domains and synaptic localization signals - synaptophysin targeting is questionable
PMID:28760822
Contradicts
AAV9 transduces astrocytes and microglia - non-cell-autonomous effects unaccounted
PMID:25369104
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — SQSTM1

No curated PDB or AlphaFold mapping for SQSTM1 yet. Search RCSB →

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for SQSTM1 (p62/sequestosome 1) from GTEx v10.

Cerebellar Hemisphere74.9 Cerebellum67.7median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for SQSTM1 (p62 →

No DepMap CRISPR Chronos data found for SQSTM1 (p62.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Rising
7d Momentum
▲ 1.5%
Volatility
Medium
0.0364
Events (7d)
3
Price History
▲11.5%

💾 Resource Usage

LLM Tokens
39,448
$0.1183
Total Cost
$0.1183

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF SQSTM1 is selectively expressed in retinal ganglion cell axons using an AAV2 retrograde vector in a mouse model of axonal lysosome deficiency (PSEN1/APP triple knock-in), THEN axonal transport of sAxonal transport velocity of synaptophysin-positive vesicles will increase by >30% (measured by in vivo imaging) and ERG photopic b-wave amplitude will normaliz— no observation —pending0.55
IF synaptic-selective SQSTM1 (p62) is overexpressed via viral transduction in primary neurons with lysosome deficiency (LAMP2 knockdown), THEN synaptic protein ubiquitination will decrease by >40% meaSynaptic protein ubiquitination will decrease by >40% (targeting known synaptic substrates like Synapsin I, PSD-95, and SV2A)— no observation —pending0.65
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF synaptic-selective SQSTM1 (p62) is overexpressed via viral transduction in primary neurons with lysosome deficiency (LAMP2 knockdown), THEN synaptic protein ubiquitination will decrease by >40% measured by targeted proteomics within 72 hours.
Predicted outcome: Synaptic protein ubiquitination will decrease by >40% (targeting known synaptic substrates like Synapsin I, PSD-95, and SV2A)
Falsification: Ubiquitinated synaptic protein levels remain unchanged or increase by >20% despite SQSTM1 overexpression, indicating failure to bypass lysosome deficiency
pendingconf 55%
IF SQSTM1 is selectively expressed in retinal ganglion cell axons using an AAV2 retrograde vector in a mouse model of axonal lysosome deficiency (PSEN1/APP triple knock-in), THEN axonal transport of synaptophysin-positive vesicles will improve by >30% and functional rescue of photopic response will
Predicted outcome: Axonal transport velocity of synaptophysin-positive vesicles will increase by >30% (measured by in vivo imaging) and ERG photopic b-wave amplitude wil
Falsification: Axonal transport defects persist unchanged or worsen, and ERG responses show no improvement, indicating SQSTM1 expression cannot compensate for lysosome deficiency in vivo
View on SciDEX ↗